Search result for 'glenmark pharma'

Pharma stocks fall after Trump announces 100% import taxes on branded drugs. Wockhardt, Sun Pharma, Natco Pharma see biggest declines.

Glenmark and Hengrui Pharma collaborate to develop and commercialize Trastuzumab Rezetecan for cancer treatment.

Glenmark Pharmaceuticals launches generic Eribulin Mesylate Injection in the US, a cancer treatment drug. Aims to provide affordable alternatives.

Glenmark Pharmaceuticals Q1 FY26 PAT drops 86% to Rs 46.97 cr due to US litigation settlement. Revenue up marginally. Read details.

Glenmark Pharma's licensing deal with AbbVie will make it cash positive, improving its financial position and liquidity, according to S&P.

Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits 52-week high.

Pharmaceutical stocks closed lower on Wednesday due to US President Trump's announcement of potential tariffs on auto, semiconductor, and pharmaceutical imports. Dr Reddy's, Zydus Lifesciences,...

Glenmark Pharmaceuticals reported a consolidated profit after tax of Rs 348 crore in Q3 FY25, driven by strong regional performance. The company also announced a USFDA inspection at its Indore...

Glenmark Pharmaceuticals and Cosmo Pharmaceuticals have received MHRA approval for Winlevi, a topical treatment for acne vulgaris in the UK. This partnership expands Glenmark's dermatology portfolio.

Glenmark Pharmaceuticals reported a consolidated profit after tax of Rs 354.49 crore in the second quarter ended on September 30, 2024, a significant turnaround from the previous year's loss. The...

Glenmark Pharmaceuticals reported a two-fold increase in net profit to Rs 340 crore for Q1 FY24, driven by strong revenue growth and improved margins.

Glenmark Pharmaceuticals has received USFDA approval for its generic Topiramate capsules used to treat seizures. The drug is bioequivalent to Topamax capsules.

Glenmark Pharmaceuticals has announced the sale of its remaining 7.84% stake in Glenmark Life Sciences through an offer for sale (OFS) valued at around Rs 778 crore.

Cipla and Glenmark are recalling drugs from the US market due to manufacturing issues, according to the USFDA. Learn more about the recalled products and reasons behind the recall.

Glenmark Pharmaceuticals receives USFDA approval to sell generic Acetaminophen and Ibuprofen tablets, a version of Advil 2 Dual Action. The company's product is expected to achieve significant...

Glenmark Pharmaceuticals expects its nasal spray Ryaltris to reach USD 80 million in sales next year, boosting revenue. The drug, commercialized in 31 markets, treats allergic rhinitis.

Glenmark Pharmaceuticals reported a net loss of Rs 351 crore in Q3 FY24, driven by lower domestic sales due to a change in distribution model. The company expects its US business to rebound in Q4.